TickerFactsScreenerDevelopers

Cellectar Biosciences, Inc. (CLRB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2002: $02009: $980.1K2010: $673.7K2011: $5.51M2012: $4.68M2013: $2.42M2014: $9.42M2015: $3.91M2016: $11.44M2017: $10.01M2018: $13.26M2019: $10.61M2020: $57.17M2021: $35.70M2022: $19.87M2023: $9.56M2024: $23.29M2025: $13.20M$13.20M
2002Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$13.20M-43.3%
2024$23.29M+143.5%
2023$9.56M-51.9%
2022$19.87M-44.4%
2021$35.70M-37.5%
2020$57.17M+438.5%
2019$10.61M-19.9%
2018$13.26M+32.5%
2017$10.01M-12.6%
2016$11.44M+192.5%
2015$3.91M-58.5%
2014$9.42M+289.6%
2013$2.42M-48.3%
2012$4.68M-15.0%
2011$5.51M+717.2%
2010$673.7K-31.3%
2009$980.1K—
2002$0—